Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States

Overview of attention for article published in Annals of Hematology, March 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#7 of 2,230)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 14 news outlets
blogs: 2 blogs

policy: 2 policy sources
twitter: 3 X users

Citations

dimensions_citation: 229 Dimensions

Readers on

mendeley: 164 Mendeley

Summary News Blogs Policy documents X Dimensions citations

So far, Altmetric has seen 2 posts from 2 blogs.

FDA Approvals Bring New Options for Older Patients with AML

Cancer Currents: An NCI Cancer Research Blog, 27 Dec 2018

FDA has approved venetoclax (Venclexta) and glasdegib (Daurismo) for use in people with acute myeloid leukemia aged 75 and…

FDA OKs Pfizer Drug for Patients Suffering From Acute Myeloid Leukemia

Scientific Computing All, 26 Nov 2018

NewsDaurismo is the first and only Hedgehog pathway inhibitor approved for the treatment of Acute Myeloid Leukemia. Contributed…